Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
629 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07728773 | A Stepped Intervention for Coping With Dyspnea in Patients With Lung Cancer-Phase A (Open Pilot)(INSPIRE) | not yet recruiting | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Jul 29, 2026 | clinicaltrials |
| NCT07734272 | Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative(STANDARDIZE-PV) | not yet recruiting | N/A | 32 | Massachusetts General HospitalOTHER | 0 |
| Jul 29, 2026 |
| clinicaltrials |
| NCT07671209 | Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention(ACCESS) | recruiting | N/A | 80 | Massachusetts General HospitalOTHER | 1 | Jul 27, 2026 | clinicaltrials |
| NCT03922555 | ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas | recruiting | Phase 1 | 18 | Massachusetts General HospitalOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT05406700 | Niraparib In Recurrent IDH 1/2 Gliomas | active not recruiting | Early Phase 1 | 16 | Massachusetts General HospitalOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT05684692 | Screening Trial for Pain Relief in Schwannomatosis (STARFISH) | recruiting | Phase 2 | 40 | Massachusetts General HospitalOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT02886585 | Pembrolizumab In Central Nervous System Metastases | active not recruiting | Phase 2 | 101 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT02896335 | Palbociclib and Pembrolizumab In Central Nervous System Metastases | recruiting | Phase 2 | 45 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT04690205 | Hospital at Home at EOL in Heme Malignancies | completed | N/A | 72 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT04992013 | Niraparib in Tumors Metastatic to the CNS | active not recruiting | Phase 2 | 20 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07077083 | CAIX PET/CT for Residual or Recurrent Post-ablative ccRCC(CAIX PET/CT) | not yet recruiting | Phase 2 | 10 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07186491 | Wearable Ultrasound Patch for Breast Imaging | not yet recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT01340495 | Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy | completed | N/A | 70 | Massachusetts General HospitalOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT05128032 | Pressure-enabled Delivery in Radioembolization (TriNav Study)(PEDIR) | completed | N/A | 29 | Massachusetts General HospitalOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT04230109 | Sacituzumab Govitecan In TNBC(NeoSTAR) | recruiting | Phase 2 | 239 | Massachusetts General HospitalOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT07711483 | GLORY: Glofit-GemOx With Liso-Cel For Lymphoma(GLORY) | not yet recruiting | Phase 2 | 56 | Massachusetts General HospitalOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT02290834 | Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer | recruiting | N/A | 200 | Massachusetts General HospitalOTHER | 1 | Jul 16, 2026 | clinicaltrials |
| NCT07707362 | Improving Care Delivery for Patients With Mental Illness and Cancer Across a Cancer Center Network(BRIDGE-NET) | not yet recruiting | N/A | 248 | Massachusetts General HospitalOTHER | 0 | Jul 16, 2026 | clinicaltrials |
| NCT07233408 | Tailoring an Online Platform to Promote Evidence-Based Care for Adults With Neurofibromatosis 1 and Low Health Literacy | recruiting | N/A | 50 | Massachusetts General HospitalOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT07405190 | Ivonescimab Alone And With Carboplatin/Pemetrexed For NSCLC | recruiting | Phase 2 | 46 | Massachusetts General HospitalOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT03716531 | Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement(PACER) | active not recruiting | N/A | 199 | Massachusetts General HospitalOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT04039230 | Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. | active not recruiting | Phase 1 / Phase 2 | 75 | Massachusetts General HospitalOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT07214987 | PDT For Induction Therapy For Head And Neck Cancer | recruiting | Phase 2 | 26 | Massachusetts General HospitalOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT07701707 | Medically Tailored Meals to Reduce Ultra-processed Food Intake in Colorectal Cancer Survivors(MTM) | not yet recruiting | N/A | 60 | Massachusetts General HospitalOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT03861975 | Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening | active not recruiting | N/A | 100 | Massachusetts General HospitalOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT05142800 | Screening For BCRL In Targeted Therapy For Breast Cancer | recruiting | — | 261 | Massachusetts General HospitalOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT05326165 | Early Intervention | not yet recruiting | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT06427954 | Mobile Application to Improve Health-Related Outcomes in Patients With Advanced Lung Cancer(THRIVE) | recruiting | N/A | 250 | Massachusetts General HospitalOTHER | 1 | Jul 13, 2026 | clinicaltrials |
| NCT06791057 | Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients With Advanced Lung Cancer(BREEZE+) | not yet recruiting | N/A | 420 | Massachusetts General HospitalOTHER | 1 | Jul 10, 2026 | clinicaltrials |
| NCT07685028 | LEGACY: Lung Cancer Screening in Individuals With a Lung Cancer Family History-Protocol A | not yet recruiting | N/A | 250 | Massachusetts General HospitalOTHER | 1 | Jul 6, 2026 | clinicaltrials |
| NCT05629442 | ctDNA and Organ Preservation/Pathologic CR in Rectal Cancer | not yet recruiting | — | 60 | Massachusetts General HospitalOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT01562405 | Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma | active not recruiting | Phase 1 | 33 | Massachusetts General HospitalOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT04827992 | Evaluation of Medical Cannabis and Prescription Opioid Taper Support for Reduction of Pain and Opioid Dose in Patients With Chronic Non-Cancer Pain | completed | N/A | 87 | Massachusetts General HospitalOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT07162337 | BILe Acid-gut Microbiome Axis MODification Through Diet Education for Colorectal Cancer Prevention(BILMOD) | recruiting | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT07247097 | ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma(ELDORADO) | not yet recruiting | Phase 2 | 160 | Massachusetts General HospitalOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT05056896 | ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | active not recruiting | Early Phase 1 | 161 | Massachusetts General HospitalOTHER | 1 | Jun 22, 2026 | clinicaltrials |
| NCT03279692 | Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma | active not recruiting | Phase 2 | 26 | Massachusetts General HospitalOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT06707493 | Ivosidenib as Post-HSCT Maintenance for AML | recruiting | Phase 2 | 75 | Massachusetts General HospitalOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT01049230 | Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors | active not recruiting | N/A | 45 | Massachusetts General HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT01346124 | High Dose Intensity Modulated Proton Radiation Treatment +/- Surgical Resection of Sarcomas of the Spine, Sacrum and Base of Skull | active not recruiting | N/A | 64 | Massachusetts General HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT01821729 | Radiation w/FOLFIRINOX-Losartan for Pancreatic Cancer | completed | Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT03362060 | PVX-410 Vaccine Plus Pembrolizumab in HLA-A2+ Metastatic Triple Negative Breast Cancer | active not recruiting | Phase 1 | 20 | Massachusetts General HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT03945721 | A Phase I Study of Niraparib Administered Concurrently With Postoperative RT in Triple Negative Breast Cancer Patients(UNITY) | active not recruiting | Phase 1 | 21 | Massachusetts General HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT04837209 | Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer(NADiR) | active not recruiting | Phase 2 | 32 | Massachusetts General HospitalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT04305145 | Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis | active not recruiting | Phase 2 | 42 | Massachusetts General HospitalOTHER | 1 | Jun 16, 2026 | clinicaltrials |
| NCT05674357 | Training in Evidence-based Treatments in Psycho-Oncology | recruiting | N/A | 115 | Massachusetts General HospitalOTHER | 1 | Jun 15, 2026 | clinicaltrials |
| NCT01148056 | Intensity Modulated Radiation Therapy (IMRT) for Patients With Rectal Cancer | terminated | N/A | 2 | Massachusetts General HospitalOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT03104439 | Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer | active not recruiting | Phase 2 | 84 | Massachusetts General HospitalOTHER | 1 | Jun 12, 2026 | clinicaltrials |
| NCT03873610 | Resiliency Training in Adolescents With NF1 and NF2 | completed | N/A | 196 | Massachusetts General HospitalOTHER | 1 | Jun 11, 2026 | clinicaltrials |
| NCT04637035 | Supportive Oncology Care at Home Post-Discharge | completed | N/A | 52 | Massachusetts General HospitalOTHER | 1 | Jun 8, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials